RICCIUTI, BIAGIO

RICCIUTI, BIAGIO  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)  

Mostra records
Risultati 1 - 20 di 54 (tempo di esecuzione: 0.032 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors Pecci F.; Nakazawa S.; Ricciuti B.; Harada G.; Lee J.K.; Alessi J.V.; Barrichello A.; Vaz V.R.; L...amberti G.; Di Federico A.; Gandhi M.M.; Gazgalis D.; Feng W.W.; Jiang J.; Baldacci S.; Locquet M.-A.; Gottlieb F.H.; Chen M.F.; Lee E.; Haradon D.; Smokovich A.; Voligny E.; Nguyen T.; Goel V.K.; Zimmerman Z.; Atwal S.; Wang X.; Bahcall M.; Heist R.S.; Iqbal S.; Gandhi N.; Elliott A.; Vanderwalde A.M.; Ma P.C.; Halmos B.; Liu S.V.; Che J.; Schrock A.B.; Drilon A.; Janne P.A.; Awad M.M. 2024-01-01 CANCER DISCOVERY - 1.01 Articolo in rivista cd-23-1217.pdf7384706.zip
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li ...Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M. 2024-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista jco-42-1311.pdf
Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities Wang X.; Lamberti G.; Di Federico A.; Alessi J.; Ferrara R.; Sholl M.L.; Awad M.M.; Vokes N.; Ric...ciuti B. 2024-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer Thummalapalli R.; Ricciuti B.; Bandlamudi C.; Muldoon D.; Rizvi H.; Elkrief A.; Luo J.; Alessi J....V.; Pecci F.; Lamberti G.; Di Federico A.; Hong L.; Zhang J.; Heymach J.V.; Gibbons D.L.; Plodkowski A.J.; Ravichandran V.; Donoghue M.T.A.; Vanderbilt C.; Ladanyi M.; Rudin C.M.; Kris M.G.; Riely G.J.; Chaft J.E.; Hellmann M.D.; Vokes N.I.; Awad M.M.; Schoenfeld A.J. 2023-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista Thummalapalli_2021.pdf6908245.zip
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC Alessi J.V.; Elkrief A.; Ricciuti B.; Wang X.; Cortellini A.; Vaz V.R.; Lamberti G.; Frias R.L.; ...Venkatraman D.; Fulgenzi C.A.M.; Pecci F.; Recondo G.; Di Federico A.; Barrichello A.; Park H.; Nishino M.; Hambelton G.M.; Egger J.V.; Ladanyi M.; Digumarthy S.; Johnson B.E.; Christiani D.C.; Lin X.; Gainor J.F.; Lin J.J.; Pinato D.J.; Schoenfeld A.J.; Awad M.M. 2023-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma Scalera S.; Ricciuti B.; Mazzotta M.; Calonaci N.; Alessi J.V.; Cipriani L.; Bon G.; Messina B.; ...Lamberti G.; Di Federico A.; Pecci F.; Milite S.; Krasniqi E.; Barba M.; Vici P.; Vecchione A.; De Nicola F.; Ciuffreda L.; Goeman F.; Fanciulli M.; Buglioni S.; Pescarmona E.; Sharma B.; Felt K.D.; Lindsay J.; Rodig S.J.; De Maria R.; Caravagna G.; Cappuzzo F.; Ciliberto G.; Awad M.M.; Maugeri-Sacca M. 2023-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC Negrao M.V.; Araujo H.A.; Lamberti G.; Cooper A.J.; Akhave N.S.; Zhou T.; Delasos L.; Hicks J.K.;... Aldea M.; Minuti G.; Hines J.; Aredo J.V.; Dennis M.J.; Chakrabarti T.; Scott S.C.; Bironzo P.; Scheffler M.; Christopoulos P.; Stenzinger A.; Riess J.W.; Kim S.Y.; Goldberg S.B.; Li M.; Wang Q.; Qing Y.; Ni Y.; Do M.T.; Lee R.; Ricciuti B.; Alessi J.V.; Wang J.; Resuli B.; Landi L.; Tseng S.-C.; Nishino M.; Digumarthy S.R.; Rinsurongkawong W.; Rinsurongkawong V.; Vaporciyan A.A.; Blumenschein G.R.; Zhang J.; Owen D.H.; Blakely C.M.; Mountzios G.; Shu C.A.; Bestvina C.M.; Garassino M.C.; Marrone K.A.; Gray J.E.; Patel S.P.; Cummings A.L.; Wakelee H.A.; Wolf J.; Scagliotti G.V.; Cappuzzo F.; Barlesi F.; Patil P.D.; Drusbosky L.; Gibbons D.L.; Meric-Bernstam F.; Lee J.J.; Heymach J.V.; Hong D.S.; Heist R.S.; Awad M.M.; Skoulidis F. 2023-01-01 CANCER DISCOVERY - 1.01 Articolo in rivista -
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study Elkrief A.; Alessi J.M.V.; Ricciuti B.; Brown S.; Rizvi H.; Preeshagul I.R.; Wang X.; Pecci F.; D...i Federico A.; Lamberti G.; Egger J.V.; Chaft J.E.; Rudin C.M.; Riely G.J.; Kris M.G.; Ladanyi M.; Chen Y.; Hellmann M.D.; Shen R.; Awad M.M.; Schoenfeld A.J. 2023-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista Elkrief_2023+suppl.pdf
Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC Alessi J.V.; Wang X.; Elkrief A.; Ricciuti B.; Li Y.Y.; Gupta H.; Spurr L.F.; Rizvi H.; Luo J.; P...ecci F.; Lamberti G.; Recondo G.; Venkatraman D.; Di Federico A.; Gandhi M.M.; Vaz V.R.; Nishino M.; Sholl L.M.; Cherniack A.D.; Ladanyi M.; Price A.; Richards A.L.; Donoghue M.; Lindsay J.; Sharma B.; Turner M.M.; Pfaff K.L.; Felt K.D.; Rodig S.J.; Lin X.; Meyerson M.L.; Johnson B.E.; Christiani D.C.; Schoenfeld A.J.; Awad M.M. 2023-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC Alessi J.V.; Ricciuti B.; Wang X.; Pecci F.; Di Federico A.; Lamberti G.; Elkrief A.; Rodig S.J.;... Lebow E.S.; Eicholz J.E.; Thor M.; Rimner A.; Schoenfeld A.J.; Chaft J.E.; Johnson B.E.; Gomez D.R.; Awad M.M.; Shaverdian N. 2023-01-01 NATURE COMMUNICATIONS - 1.01 Articolo in rivista Alessi_2023.pdf41467_2023_39874_MOESM1_ESM.pdf
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer Di Federico A.; Ricciotti I.; Favorito V.; Michelina S.V.; Scaparone P.; Metro G.; De Giglio A.; ...Pecci F.; Lamberti G.; Ambrogio C.; Ricciuti B. 2023-01-01 CURRENT ONCOLOGY REPORTS - 1.01 Articolo in rivista -
The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks De Giglio A.; Ricciuti B.; Metro G. 2023-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista dic.2022-11-4.pdf
Title: Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer Ricciuti B.; Elkrief A.; Alessi J.; Wang X.; Li Y.; Gupta H.; Muldoon D.M.; Bertram A.A.; Pecci F....; Lamberti G.; Di Federico A.; Barrichello A.; Vaz V.R.; Gandhi M.; Lee E.; Shapiro G.I.; Park H.; Nishino M.; Lindsay J.; Felt K.D.; Sharma B.; Cherniack A.D.; Rodig S.; Gomez D.R.; Shaverdian N.; Rakaee M.; Bandlamudi C.; Ladanyi M.; Janne P.A.; Schoenfeld A.J.; Sholl L.M.; Awad M.M.; Cheng M.L. 2023-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions Cortellini A.; Barrichello A.P.C.; Alessi J.V.; Ricciuti B.; Vaz V.R.; Newsom-Davis T.; Evans J.S....; Lamberti G.; Pecci F.; Viola P.; D'Alessio A.; Fulgenzi C.A.M.; Awad M.M.; Pinato D.J. 2022-01-01 ANNALS OF ONCOLOGY - 1.04 Replica / breve intervento (e simili) -
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease Metro G.; De Giglio A.; Ricciuti B.; Siringo M.; Marinelli D.; Gelibter A.; Pecci F.; Berardi R.;... Cantini L.; Di Federico A.; Andrini E.; Mosca M.; Lamberti G.; Brambilla M.; Mountzios G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista -
Advanced non-small-cell lung cancer: how to manage non-oncogene disease De Giglio A.; Di Federico A.; Deiana C.; Ricciuti B.; Brambilla M.; Metro G. 2022-01-01 DRUGS IN CONTEXT - 1.01 Articolo in rivista dic.2022-2-4.pdf
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers with Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels Ricciuti B.; Wang X.; Alessi J.V.; Rizvi H.; Mahadevan N.R.; Li Y.Y.; Polio A.; Lindsay J.; Umeto...n R.; Sinha R.; Vokes N.I.; Recondo G.; Lamberti G.; Lawrence M.; Vaz V.R.; Leonardi G.C.; Plodkowski A.J.; Gupta H.; Cherniack A.D.; Tolstorukov M.Y.; Sharma B.; Felt K.D.; Gainor J.F.; Ravi A.; Getz G.; Schalper K.A.; Henick B.; Forde P.; Anagnostou V.; Janne P.A.; Van Allen E.M.; Nishino M.; Sholl L.M.; Christiani D.C.; Lin X.; Rodig S.J.; Hellmann M.D.; Awad M.M. 2022-01-01 JAMA ONCOLOGY - 1.01 Articolo in rivista jamaoncology_ricciuti_2022_oi_220022_1671559773.22536(1).pdfjamaoncol-e221981-s001.pdf
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities De Giglio A.; Orlando V.; Andrini E.; Ricciuti B.; Lamberti G.; Chiari R. 2022-01-01 TUMORI - 1.01 Articolo in rivista -
Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status Ricciuti B.; Arbour K.C.; Lin J.J.; Vajdi A.; Vokes N.; Hong L.; Zhang J.; Tolstorukov M.Y.; Li Y....Y.; Spurr L.F.; Cherniack A.D.; Recondo G.; Lamberti G.; Wang X.; Venkatraman D.; Alessi J.V.; Vaz V.R.; Rizvi H.; Egger J.; Plodkowski A.J.; Khosrowjerdi S.; Digumarthy S.; Park H.; Vaz N.; Nishino M.; Sholl L.M.; Barbie D.; Altan M.; Heymach J.V.; Skoulidis F.; Gainor J.F.; Hellmann M.D.; Awad M.M. 2022-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer Ricciuti B.; Alessi J.V.; Elkrief A.; Wang X.; Cortellini A.; Li Y.Y.; Vaz V.R.; Gupta H.; Pecci ...F.; Barrichello A.; Lamberti G.; Nguyen T.; Lindsay J.; Sharma B.; Felt K.; Rodig S.J.; Nishino M.; Sholl L.M.; Barbie D.A.; Negrao M.V.; Zhang J.; Cherniack A.D.; Heymach J.V.; Meyerson M.; Ambrogio C.; Janne P.A.; Arbour K.C.; Pinato D.J.; Skoulidis F.; Schoenfeld A.J.; Awad M.M.; Luo J. 2022-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -